Variable response to radioactive iodine treatment in poorly differentiated thyroid carcinoma

Affiliations

¹ Division of Endocrine Surgery, NYU Langone Health, New York, NY, USA.
² Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Editorial

Hunter J Underwood et al. Gland Surg. 2019 Dec.

. 2019 Dec;8(6):589-590.

doi: 10.21037/gs.2019.10.14.

¹ Division of Endocrine Surgery, NYU Langone Health, New York, NY, USA.
² Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
Nikitski AV, Rominski SL, Condello V, Kaya C, Wankhede M, Panebianco F, Yang H, Altschuler DL, Nikiforov YE. Nikitski AV, et al. Thyroid. 2019 Oct;29(10):1425-1437. doi: 10.1089/thy.2019.0284. Epub 2019 Aug 16. Thyroid. 2019. PMID: 31298630 Free PMC article.

The role of external beam radiation therapy in the management of thyroid carcinomas: A retrospective study in Iran Cancer Institute.
Esmati E, Aleyasin A, Ghalehtaki R, Jafari F, Farhan F, Aghili M, Haddad P, Kazemian A. Esmati E, et al. Cancer Rep (Hoboken). 2023 Jan;6(1):e1652. doi: 10.1002/cnr2.1652. Epub 2022 Jun 12. Cancer Rep (Hoboken). 2023. PMID: 35691611 Free PMC article.
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC.
Kersting D, Seifert R, Kessler L, Herrmann K, Theurer S, Brandenburg T, Dralle H, Weber F, Umutlu L, Führer-Sakel D, Görges R, Rischpler C, Weber M. Kersting D, et al. Cancers (Basel). 2021 Apr 6;13(7):1728. doi: 10.3390/cancers13071728. Cancers (Basel). 2021. PMID: 33917322 Free PMC article.
An Unexpected Finding of Poorly Differentiated Thyroid Carcinoma in a Toxic Thyroid Nodule.
Yuang K, Al-Bahadili H, Chang A. Yuang K, et al. JCEM Case Rep. 2023 May 23;1(3):luad052. doi: 10.1210/jcemcr/luad052. eCollection 2023 May. JCEM Case Rep. 2023. PMID: 37908574 Free PMC article.
Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation - association or random chance?
Johansson K, Stenman A, Paulsson JO, Wang N, Ihre-Lundgren C, Zedenius J, Juhlin CC. Johansson K, et al. Thyroid Res. 2021 Aug 14;14(1):19. doi: 10.1186/s13044-021-00110-4. Thyroid Res. 2021. PMID: 34389035 Free PMC article.

1. Janz TA, Neskey DM, Nguyen SA, et al. Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study. World J Otorhinolaryngol Head Neck Surg 2018;5:34-40. 10.1016/j.wjorl.2018.05.006 - DOI - PMC - PubMed
1. Nikiforov YE. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol 2004;15:319-27. 10.1385/EP:15:4:319 - DOI - PubMed
1. Sadow PM, Faquin WC. Poorly differentiated thyroid carcinoma: an incubating entity. Front Endocrinol (Lausanne) 2012;3:77. - PMC - PubMed
1. McFadden DG, Vernon A, Santiago PM, et al. p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer. Proc Natl Acad Sci U S A 2014;111:E1600-9. 10.1073/pnas.1404357111 - DOI - PMC - PubMed
1. Nikitski AV, Rominski SL, Condello V, et al. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma. Thyroid 2019;29:1425-37. 10.1089/thy.2019.0284 - DOI - PMC - PubMed